MX2023003360A - Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. - Google Patents

Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.

Info

Publication number
MX2023003360A
MX2023003360A MX2023003360A MX2023003360A MX2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A MX 2023003360 A MX2023003360 A MX 2023003360A
Authority
MX
Mexico
Prior art keywords
methods
associated disorders
receptor pathway
melanocortin
treating
Prior art date
Application number
MX2023003360A
Other languages
English (en)
Spanish (es)
Inventor
Der Ploeg Leonardus H T Van
Alastair Garfield
Bhavik P Shah
Original Assignee
Rhythm Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhythm Pharmaceuticals Inc filed Critical Rhythm Pharmaceuticals Inc
Publication of MX2023003360A publication Critical patent/MX2023003360A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
MX2023003360A 2020-09-24 2021-09-24 Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. MX2023003360A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063082867P 2020-09-24 2020-09-24
PCT/US2021/052032 WO2022067086A1 (en) 2020-09-24 2021-09-24 Methods of treating melanocortin-4 receptor pathway-associated disorders

Publications (1)

Publication Number Publication Date
MX2023003360A true MX2023003360A (es) 2023-06-23

Family

ID=80845850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003360A MX2023003360A (es) 2020-09-24 2021-09-24 Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.

Country Status (13)

Country Link
US (1) US20240058414A1 (https=)
EP (1) EP4216979A4 (https=)
JP (1) JP2023542985A (https=)
KR (1) KR20230095956A (https=)
CN (1) CN116507353A (https=)
AR (1) AR123603A1 (https=)
AU (1) AU2021350017A1 (https=)
CA (1) CA3192873A1 (https=)
CL (1) CL2023000823A1 (https=)
CO (1) CO2022009561A2 (https=)
MX (1) MX2023003360A (https=)
TW (1) TW202228760A (https=)
WO (1) WO2022067086A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4554607A2 (en) * 2022-07-12 2025-05-21 Rhythm Pharmaceuticals, Inc. Methods for treating obesity with an mc4r agonist
WO2024108198A2 (en) * 2022-11-18 2024-05-23 Rhythm Pharmaceuticals, Inc. Methods of treating obesity with an mc4r agonist
TW202535448A (zh) * 2023-11-14 2025-09-16 美商律森製藥股份有限公司 鉀通道活化劑與mc4r促效劑之組合及相關使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ565217A (en) * 2005-07-08 2010-03-26 Ipsen Pharma Sas Melanocortin receptor ligands
EP2970388B1 (en) * 2013-03-15 2018-07-25 Rhythm Pharmaceuticals, Inc. Peptide compositions
PL3356386T3 (pl) * 2015-09-30 2024-08-05 Rhythm Pharmaceuticals, Inc. Sposób leczenia zaburzeń związanych ze szlakiem receptora melanokortyny 4

Also Published As

Publication number Publication date
AU2021350017A9 (en) 2024-10-03
TW202228760A (zh) 2022-08-01
KR20230095956A (ko) 2023-06-29
EP4216979A4 (en) 2024-11-06
AU2021350017A1 (en) 2023-05-04
CO2022009561A2 (es) 2022-07-19
US20240058414A1 (en) 2024-02-22
CA3192873A1 (en) 2022-03-31
CN116507353A (zh) 2023-07-28
EP4216979A1 (en) 2023-08-02
AR123603A1 (es) 2022-12-21
WO2022067086A1 (en) 2022-03-31
CL2023000823A1 (es) 2023-09-15
JP2023542985A (ja) 2023-10-12

Similar Documents

Publication Publication Date Title
MX2023003360A (es) Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4.
Wilson et al. Effects of acoustic–phonetic detail on cross-language speech production
NZ745425A (en) G protein-coupled receptor (gpcr) modulation by imipridones
MX2024010244A (es) Uso de un inhibidor del receptor de interleucina-4 (il-4r) para tratar la dermatitis atopica.
NO20084486L (no) Vanninjeksjonssystemer og -metoder
GB2528586A (en) Treatment of a subterranean formation with composition including a microorganism or compound generated by the same
GB2460968A (en) Method and system for recovering aromatics from a naphtha feedstock
GB2460189A (en) System and method for performing oilfield drilling operations using visualization techniques
ATE522857T1 (de) Verfahren, vorrichtung, server, system und computerprogrammprodukt zur verwendung mit prädiktiver texteingabe
WO2018226958A8 (en) T cells expressing a chimeric antigen receptor
GB201212435D0 (en) A transcription device and a method for transcribing speech
NO20083433L (no) Avleiringshemmende bronnbehandling
WO2023086428A3 (en) Novel modulators of the aryl hydrocarbon receptor and methods of use thereof
IL290101A (en) Methods for the treatment of antibody-mediated diseases with the help of fcrn antagonists
MY153565A (en) Soft landing system and method of achieving same
NO20090661L (no) Fremgangsmate for a fjerne forurensninger fra produsert vann
GB2538912A (en) Rod hang-off system
WO2022020755A3 (en) Biomarkers and methods of selecting and using the same
JOP20210048B1 (ar) أجسام مضادة مساعدة لـ cd200r واستخداماتها
CL2025000071A1 (es) Métodos para tratar la obesidad con un agonista de mc4r
MX369733B (es) Transmisión de datos de pozo de petróleo desde una plataforma de perforación móvil.
EA201791195A1 (ru) Способ получения lpg и btx
MX2025005716A (es) Métodos para tratar la obesidad con un agonista de mc4r
MX2019014682A (es) Aparatos, sistemas y metodos para mejorar los soportes estructurales verticales.
MX2023010682A (es) Herramienta de apoyo a la toma de decisiones de coincidencia de componentes.